Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Zonisamide reduces tremor scores in patients with essential tremor

March 4, 2009

Taisho scientists present new antidepressive NMU2 ligands

March 4, 2009

Intellect Neurosciences' AD candidate Oxigon reported to have copper-binding properties

March 4, 2009

Marinus presents successful results from phase II ganaxolone trial

March 3, 2009

Endo licenses axomadol and returns rights to Transdur-sufentanil

March 3, 2009

Astellas and XenoPort announce results from phase II ASP-8825/XP-13512 trial

March 3, 2009

AstraZeneca receives FDA complete response letter for Seroquel XR sNDA

March 2, 2009

Somaxon receives FDA complete response letter for Silenor

March 2, 2009

New venlafaxine prodrugs for depression imparted by Solvay

March 2, 2009

Eisai and Teikoku Seiyaku sign option and license agreement for donepezil

Feb. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...